Concepedia
Publication | Open Access
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease
173
Citations
33
References
2022
Year
ClinicalTrials.gov Identifier: NCT03289143.
Page 1